Free Trial
TSE:GLG

GLG Life Tech (GLG) Stock Price, News & Analysis

GLG Life Tech logo

About GLG Life Tech Stock (TSE:GLG)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
15,000 shs
Average Volume
10,228 shs
Market Capitalization
C$1.92 million
P/E Ratio
N/A
Dividend Yield
5.68%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GLG Life Tech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GLG Stock News Headlines

GLG Life Tech: Q4 Earnings Snapshot
Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Genetic Technologies Reduces Costs and Expands Global Reach
See More Headlines

GLG Stock Analysis - Frequently Asked Questions

Shares of GLG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that GLG Life Tech investors own include BELLUS Health (BLU), Gold Resource (GORO), 36Kr (KRKR), Ocean Power Technologies (OPTT), Abeona Therapeutics (ABEO), Aadi Bioscience (AADI) and ARCA biopharma (ABIO).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Farm Products
Sub-Industry
N/A
Current Symbol
TSE:GLG
CIK
N/A
Fax
N/A
Employees
86
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$32.45 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-2.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.03
Quick Ratio
0.02

Sales & Book Value

Annual Sales
C$8.99 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
8.57
Book Value
C($4.95) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
38,390,000
Free Float
N/A
Market Cap
C$1.92 million
Optionable
Not Optionable
Beta
2.06
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (TSE:GLG) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners